Previous 10 | Next 10 |
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (Nasdaq CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, publishes today its financi...
Promising preclinical results obtained in obesity support the OBA Phase 2 clinical study expected to start mid-2024 PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 8, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotec...
All resolutions presented by the Company have been adopted PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 4, 2024 / Biophytis SA (NASDAQ CM BPTS),(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of ther...
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes asso...
2023-11-17 17:23:20 ET More on Biophytis Biophytis receives notice of delisting from Nasdaq Biophytis and Skyepharma sign partnership agreement for production of Sarconeos For further details see: Biophytis SA receives non compliance notice from Nasdaq
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 30,2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), («Biophytis»), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associa...
2023-10-27 17:24:16 ET More on Biophytis Biophytis and Skyepharma sign partnership agreement for production of Sarconeos Seeking Alpha’s Quant Rating on Biophytis Historical earnings data for Biophytis Financial information for Biophytis For fu...
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 27, 2023 / Biophytis SA (NASDAQ CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with ...
2023-09-29 16:58:27 ET DENVER, Colo., Sept 29, 2023 ( www.247marketnews.com )- It was like this week shot out of a canon. Monday We started the week by covering Biophytis SA (NASDAQ: BPTS) and Skyepharma signing a partnership agreement for the production of regulatory batche...
2023-09-28 11:15:39 ET More on Biophytis Biophytis and Skyepharma sign partnership agreement for production of Sarconeos Seeking Alpha’s Quant Rating on Biophytis Historical earnings data for Biophytis Financial information for Biophytis For fu...
News, Short Squeeze, Breakout and More Instantly...
Biophytis SA Company Name:
BPTS Stock Symbol:
NASDAQ Market:
ADSs delisted from Nasdaq, which will result in meaningful savings ADSs transferred to OTC Pink market; Company will apply to trade on OTCQB market Biophytis remains listed on Euronext Growth Paris as its primary trading market PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 2...
A look at the top 10 most actives in the United States Cyngn Inc. (CYN) rose 90.2% to $0.2302 on volume of 145,513,222 shares Pineapple Energy Inc. (PEGY) rose 47.8% to $0.0677 on volume of 101,675,442 shares AGBA Group Holding Limited (AGBA) rose 8.7% to $2.7186 on volume of 17,457,670 s...
2024-04-22 09:02:03 ET Biophytis (BPTS) announced stock split at a ratio of 1-for-40 on 2024-04-23 ... Full story available on KlickAnalytics.com